Current perspectives on antiangiogenesis strategies in the treatment of malignant gliomas
Authors:
- Philip C de Witt HamerPHPhilip C de Witt Hamer
- Antonella N WitmerAWAntonella N Witmer
- Dirk TroostDTDirk Troost
- Cornelis J.F van NoordenCNCornelis J.F van Noorden
- 1 July 2004
- journal article
- review article
- Published by Elsevier in Brain Research Reviews
- Vol. 45 (3) , 143-163
Abstract
No abstract availableKeywords
This publication has 143 references indexed in Scilit:
- Clinical translation of angiogenesis inhibitorsNature Reviews Cancer, 2002
- Structural basis for the recognition of hydroxyproline in HIF-1α by pVHLNature, 2002
- Metronomic scheduling: the future of chemotherapy?The Lancet Oncology, 2001
- Anti-angiogenic agentsEuropean Journal of Cancer, 2000
- The Hallmarks of CancerCell, 2000
- Placenta Growth Factor: Identification and Characterization of a Novel Isoform Generated by RNA Alternative SplicingBiochemical and Biophysical Research Communications, 1997
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisCell, 1996
- Abnormal blood vessel development and lethality in embryos lacking a single VEGF alleleNature, 1996
- Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivoNature, 1993
- Induction of angiogenesis during the transition from hyperplasia to neoplasiaNature, 1989